Clinical Trial Diversity Requirements in 2026
Clinical trial diversity requirements are becoming a central component of regulatory expectations in the United States as the biomedical industry moves into 2026. Historically, clinical research populations have often failed to reflect the demographic composition of the patients who ultimately use approved therapies. In response, regulators, policymakers, and research institutions are strengthening expectations for inclusive … Read more